The kinetic behaviour of many drugs is different in obese patients compared with non-obese patients, depending on factors related both to obesity and to the drug used. 1 -3 Both fat and lean body mass increase in the obese individual, although there is a relative decrease in lean body mass; water content and blood flow per gram of fat tissue are reduced in obese patients compared with non-obese subjects. 4 -7 For these reasons, obesity is likely to increase the degree of importance of partition coefficients (l blood/gas , l oil/gas ) of inhaled drugs as total body weight and duration of anaesthesia increase.
The new fluorinated agents have markedly improved the quality and the time required for recovery compared with the older inhaled anaesthetics. Desflurane, in particular, is a new fluorinated anaesthetic agent with a very low blood-gas partition coefficient (about 30% less than sevoflurane) and low oil-gas partition coefficient (about 64% less than sevoflurane), which allow for quick modification of the anaesthetic plan and rapid emergence at the end of surgery, 8 -10 even in obese patients. Nonetheless, obesity markedly affects the cardiovascular and respiratory systems, the proportion of different tissues in body composition, and perfusion, uptake, and solubility. These changes can potentially affect not only wash-in and wash-out kinetics of the aforesaid new inhalational agents, but also recovery times in obese patients. Although desflurane has shown a significantly better recovery profile compared with propofol and isoflurane 10 in obese patients, there is still some grade of uncertainty between desflurane and sevoflurane. This could have been caused partially by the poor study designs used (e.g. anaesthetics were not carefully titrated) and partially by the use of premedication. These causes may have masked the theoretical differences between these two halogenated gases.
The aim of this prospective, randomized, double-blind study was to compare wash-in and wash-out curves and recovery times after sevoflurane vs desflurane anaesthesia in morbidly obese patients when no premedication had been used, and careful titration of drugs was possible thanks to a bispectral (BIS) index monitor.
Methods
Twenty-eight patients [ASA physical status II-III, age 37.1 (SD 12.9) yr, BMI 50.6 (5.4)] scheduled for elective bilio-intestinal bypass surgery were prospectively studied. Patients with ASA physical status.III, aged ,20 or .65 yr, with a history of alcohol or drug abuse, or with heart dysfunctions were excluded.
Patients fasted for 8 h before surgery and received no premedication. After arrival in the operating room, two 18-gauge i.v. cannulas were inserted in the forearm, and Ringer's lactate solution 7 ml kg 21 was infused. A radial artery catheter was inserted for invasive arterial pressure monitoring. Standard monitoring, including electrocardiography, heart rate (Lead II), and pulse oximetry, was used throughout the study. In each patient, the BIS index was also monitored using an EEG monitor (BIS XP electrodes for an A 2000 monitor; Aspect Medical Systems Inc., Natick, MA, USA). Neuromuscular block was assessed by the response to single twitch stimuli at 0.1 Hz during the onset time and subsequently by train-of-four (TOF) stimulation at a frequency of four stimuli at 2 Hz interposed by a 10 s interval with surface electrodes placed at the wrist for ulnar nerve stimulation. All patients were intubated using a flexible fibreoptic bronchoscopic technique facilitated by target-controlled infusion (TCI) of remifentanil set at 2.5 mg ml 21 . After tracheal intubation, general anaesthesia was induced with propofol 2 mg kg
21
. Ventilation was assisted with oxygen 50% in air mixture and then mechanically controlled using a non-rebreathing system. Lung ventilation was adjusted to maintain an endtidal partial pressure of carbon dioxide ranging between 32 and 35 mm Hg and facilitated by cis-atracurium as neuromuscular blocking agent.
Remifentanil was administered using a pharmacokinetic model-driven, computer-assisted continuous infusion system allowing constant target concentrations to be achieved and maintained. The system consisted of an Acer TravelMate 518TX computer connected to a Graseby 3500 infusion pump (Sims Graseby Limited, Waterford, Herts, UK) using the Rugloop software (designed by Tom De Smet and Michel Struys, Department of Anaesthesia, University Hospital, Ghent, Belgium). The pharmacokinetic parameters used in the computer-assisted continuous infusion for the administration of remifentanil were based on the model described by Minto and colleagues. 11 12 For remifentanil TCI, weight was corrected according to the formula suggested by Lemmens and colleagues: 13 Ideal body weight¼22ÂH 2 (m).
Immediately after the stabilization of the ventilatory parameters, the patients were randomly assigned either to the sevoflurane group (n¼14) or to the desflurane group (n¼14), and a square-wave of either sevoflurane 2% or desflurane 6% was administered for 30 min via the nonrebreathing circuit. The sampling of inspired (F I ) and end-tidal (F A ) gases was carried out by means of an infrared gas analyser (RMG 5250, Ohmeda), previously calibrated according to the manufacturer's instructions.
The kinetics of sevoflurane and desflurane were determined by collecting end-tidal gas samples from first breaths at 1, 5, 10, 15, 20, 25, and 30 min; then the surgical procedure started. During the surgery, anaesthesia was maintained with either sevoflurane 1 -2% or desflurane 3 -4% in an oxygen/air mixture (FI O 2 ) adapted to the needs of each patient in order to maintain stable BIS values ranging from 40 to 50. Target remifentanil concentration was modified after the first surgical stimulus had occurred and titrated to maintain heart rate and arterial pressure within +10% of baseline values.
While the peritoneum was being sutured, morphine sulphate 0.05 mg kg -1 and ketorolac 30 mg were administered to control the early acute postoperative pain.
During the last 20 min of each case, the end-expiratory anaesthetic concentration was gradually titrated in order to achieve a BIS value of 60. Near the end of the surgery, residual neuromuscular block was antagonized with prostigmine 2 mg and atropine 1 mg. Remifentanil was discontinued when the surgeon started the skin suture. After the last skin stitch, fresh gas flows were increased to 10 litre min 21 and the end-tidal concentration of anaesthetic gases was recorded from five consecutive breaths immediately before discontinuing their administration; then end-tidal samples of inhalational agents were collected at 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, and 5 min after suspension.
Mechanical ventilation was maintained until the first spontaneous breath occurred; then lung ventilation was manually assisted with oxygen 100%, and the tracheal tube was removed when a TOF ratio above 0.9 was reached.
A blinded observer recorded the time from discontinuation of the anaesthetic drug to eye opening after verbal command, squeezing the observer's hand, extubation, ability to state their name and give their correct date of birth, and discharge from the recovery room, and the duration of the surgery and anaesthesia.
Power was calculated using previous reports. After a mean duration of anaesthetic procedure of 258 min, Strum and colleagues 14 reported a time to initial response to command of 18.5 (8.7) min after sevoflurane anaesthesia in morbidly obese patients. During desflurane anaesthesia, we considered significant a 50% reduction of initial response to command so that the sample size was estimated as 14 patients for each group with an a error of 0.05 and a power of 0.8.
Statistical analysis was performed using the program Statistica 5.0 (StatSoft Italia, Vigonza, Padova, Italy). Normality for every variable was assessed by means of Kolmogorov -Smirnov test. A two-way analysis of variance for repeated measures extended by Sheffe's post hoc test was used to analyse changes over time. Student's t-test was used when appropriate. Ordinal data were analysed using the contingency table analysis using Fisher's exact test. Continuous variables are presented as mean and SD, whereas ordinal data are presented as number (%). A value of P,0.05 was considered significant.
Results
No differences in age [34. 3 (13.9) Figure 1 shows the wash-in curve measured in the sevoflurane and desflurane groups. The desflurane group shows a higher F A /F I ratio during the total observation period, although it is statistically significant only from the 15th to the 30th min (Table 2) . Figure 2 shows the wash-out curve for the same groups of patients. The F A /F A0 ratio is significantly higher in the desflurane group during the total observation period (Table 3) .
Patients in the desflurane group reported early recovery times compared with those of sevoflurane group (Table 4) . In particular, the time from discontinuation of the anaesthetic drug to eye opening after verbal command, squeezing the observer's hand, extubation, and ability to state their name and give their correct date of birth are all significantly shorter at the 0.001 level. The time from discontinuation of the anaesthetic drug to discharge from the recovery room is also significantly shorter in the desflurane group (P,0.001).
Discussion
The results of this prospective, randomized, double-blind study show faster wash-in and wash-out for desflurane compared with sevoflurane in morbidly obese patients. This is consistent with its very low blood -gas partition coefficient (l blood/gas about 30% less than sevoflurane) and its low oil -gas partition coefficient (l oil/gas about 64% less than sevoflurane), 8 9 which suggest a more rapid kinetic profile. For this reason, desflurane could be more Faster wash-out and recovery for desflurane vs sevoflurane suitable for morbidly obese patients. In fact, it is safe and effective in maintaining balanced general anaesthesia, and its use is followed by rapid recovery. 10 Although absorption by/delivery to body tissues is mainly determined by drug solubility, 15 few studies have compared the kinetic curves of sevoflurane and desflurane in obese patients. Three factors govern the uptake and distribution of potent inhaled anaesthetics. Cardiac output, alveolar-to-venous partial pressure difference, and solubility in blood, defined as the blood -gas partition coefficient, contribute to the wash-in curves observed in different ways. These wash-in curves show a higher F A /F I ratio in the desflurane group compared with the sevoflurane group from the 15th to the 30th min. As reported in non-obese patients, this result can be explained by the slower distribution of desflurane to the peripheral compartments, 16 which in turn causes a more rapid saturation of the central compartment. In fact, the apparent distribution volume of desflurane is smaller than the apparent distribution volume of sevoflurane, 16 therefore the uptake of desflurane is lower. As far as the anaesthetic uptake from the baseline to the 15th min is concerned, desflurane has a higher F A /F I ratio, that is not, however, statistically significant in our study. At the beginning of anaesthesia, alveolar-to-venous partial pressure is maximal because no inhalational agent is present in mixed venous blood. As a result, initially, uptake is proportional to the blood solubility multiplied by the cardiac output. Although we used equal MAC fractions of anaesthetics during the wash-in phase, the similar wash-in curves observed from the baseline to the 15th min between sevoflurane and desflurane could have been because of a lower cardiac output during this period in the sevoflurane group compared with the desflurane group. In theory, a lower cardiac output in the sevoflurane group could have offset its higher solubility, resulting in an uptake similar to that of desflurane.
In contrast, the wash-out phase of desflurane was significantly shorter than that of sevoflurane during the total observation period, suggesting faster clearance of desflurane compared with sevoflurane. This result can be explained both by a larger amount of tissue deposits and by the higher blood-gas partition coefficient of sevoflurane, causing a slower rate of decrease both in the arterial circulation and from the lungs. This, in turn, allows the anaesthetic to recirculate and delays the wash-out. Despite the numerically similar difference between sevoflurane -in values recorded at 1, 5, 10, 15, 20, 25 , and 30 min after starting the administration of halogenated gases. Data are presented as mean (SD). A value of P,0.05 was considered significant and desflurane values during the wash-in and wash-out phases and despite the fact that both are statistically significant, the difference during the emergence from anaesthesia is particularly important because of its clinical significance. In fact, the first can be easily compensated for by an increase in the delivered agent, whereas the second cannot. As we show in this paper, this results in important clinical differences as far as recovery times are concerned.
The wash-in and wash-out curves of desflurane and sevoflurane were determined in an oxygen -air mixture, excluding a second gas effect. 17 However, the kinetic curves of inhalational agents can also be influenced both by the surgical procedure and by changes in the cardiovascular function. In our study, surgeons performed open bariatric surgery, excluding those cardiovascular modifications related to laparoscopic procedures. 18 Moreover, the inhalational agent (Fi) was adapted to the needs of each patient to maintain stable BIS values ranging between 40 and 50, whereas the effect-site concentration of remifentanil was titrated to maintain heart rate and arterial pressure within +10% of baseline values. Furthermore, near the end of surgery, the BIS index value was gradually titrated to 60 in both groups. This anaesthetic technique minimized not only the cardiovascular effects, which could have potentially affected the kinetic profile of the inhalational agents, and the sympathetic responses to abdominal surgery, 19 but also a possible delay in wash-out or recovery because of a significantly different level of hypnosis.
The use of an infrared analyser for the quantification of the concentration of volatile anaesthetic agents instead of gas chromatography could be considered a possible shortcoming of this study. The determination of the kinetic profiles of inhalational agents using respiratory gas analysis is an established method. 20 21 Traditionally, gas chromatography assays have been used. In this study, we used the data that are routinely available from anaesthetic workstations. As described by Rietbrock and colleagues, 22 the data gathered during routine monitoring are sufficient to provide reliable estimates of the pharmacokinetic parameters, especially when a non-rebreathing circuit is used.
As regards recovery, we decided to evaluate recovery profiles when anaesthetic gas delivery was carefully titrated using the BIS index and no premedication had been used. Our results are in contrast with those of another study which tried to evaluate recovery profiles of desflurane vs sevoflurane in morbidly obese patients when anaesthetic delivery had been titrated according to the BIS index, especially near the end of surgery. 23 -25 This difference can be explained by our use of only the ultra-short-acting opioid remifentanil and the inhalational agent, avoiding other drugs, such as midazolam, and a long-acting opioid such as fentanyl, which could smooth out or even abolish recovery differences.
Our results show a statistically (and also clinically) significant difference between the recovery profiles of patients who received desflurane vs sevoflurane. These data are consistent with the faster kinetic profile of desflurane and its faster wash-out from the body. For desflurane, time from discontinuation of the anaesthetic gas to eye opening on verbal command, squeezing the observer's hand on command, extubation, stating their name, giving their correct date of birth, and discharge from the recovery room were all significantly shorter at a 0.001 level (Table 4) . Our results conform with those of Strum and colleagues, 14 even though they administered midazolam as premedication. De Baerdemaeker and colleagues 26 also demonstrated faster wash-out and recovery times using an inhalation bolus technique to optimize anaesthetic administration to morbidly obese patients. Desflurane has demonstrated its rapidity and consistency in recovery times even compared with propofol and isoflurane. 10 Although few studies have been carried out in obese patients, the effects of desflurane and sevoflurane on the non-obese population are well known. Behne and colleagues 27 reported no significant differences between desflurane, sevoflurane, or isoflurane, but patients in their study were premedicated and no EEG monitor was used. Others 28 reported that sevoflurane was associated with a slower emergence from anaesthesia than desflurane after minor gynaecological laparoscopic surgery, but recovery of cognitive function and discharge times were similar in the two anaesthetic groups. Indeed, they used a long-acting opioid such as fentanyl, and no EEG monitor and no premedication drug was used. According to Tarazi and Philip, 29 sevoflurane provided a faster recovery, even though not in a statistically significant manner. Larsen and colleagues 30 reported that propofol was associated with a better emergence compared with sevoflurane and desflurane, with no significant difference between them. After 30 min, desflurane resulted in a superior quality of recovery compared with sevoflurane. Finally, Eger and colleagues 31 showed that recovery was faster with desflurane, whatever the duration of anaesthesia.
In conclusion, our study confirms the more rapid kinetic profile of desflurane, which results in faster recovery when its administration is carefully titrated according to the BIS index value and when no premedication drugs are used.
